Lastest News
At Profound Research, every team member plays a crucial role in advancing our mission of improving lives through advanced therapeutic options. Today, we’re excited …
November 18, 2024
At Profound Research, our commitment to quality goes beyond compliance; it's a core value that guides our mission to improve lives through advanced therapeutic …
November 14, 2024
As we continue our celebration of World Quality Week, we’re excited to spotlight one of the talented team members who drives Profound Research’s commitment …
November 13, 2024
As Profound Research celebrates World Quality Week, we’re excited to highlight one of our Quality Team members whose dedication exemplifies our mission and values. …
November 12, 2024
Alzheimer’s disease (AD) is a major global health issue, with over 55 million people affected worldwide. Early detection of AD is challenging, as there …
September 20, 2024
Profound Research (Profound), a leading clinical site network, and Cardiology and Vascular Associates (CAVA), a prominent cardiology and vascular medicine group, have announced a …
August 6, 2024
Profound Research, a leading clinical trial site network, today announced the key leadership appointment of Michael Shipton as Chief Commercial Officer, a move aimed …
August 6, 2024
Celebrating a Milestone in Alzheimer's Treatment Profound Research extends our heartfelt congratulations to our sponsor partner, Eli Lilly, on the recent approval of Kinsunla™ …
July 3, 2024
At Profound Research, we are dedicated to delivering clinical trials and advanced therapies to diverse communities across the nation. Today, we are thrilled to …
June 28, 2024
At Profound Research, we're committed to highlighting the individuals who are advancing medical science and patient care through their work in clinical research. Today, …
April 18, 2024
